Search Results - "Rosado María, MC"

DI-062 New direct acting antiviral based therapies in hiv/hcv coinfected patients: management and effectiveness in a study population by Romeo, A Llorente, Torrón, AM Martinez, Carbajo, AI Iglesias, María, MC Rosado

“…BackgroundTreatment of HIV/HCV coinfected patients requires attention to the complex drug interactions that can occur between new direct acting antivirals…”
Get full text

5PSQ-103 Experience of antifibrotic agents in the treatment of idiopathic pulmonary fibrosis by Menárguez Blanc, R, García Jimenez, V, Rosado María, MC, Arias Martínez, A, Zárate Tamames, B, López, Á Pieras, Álvarez Asteinza, C, Maray Mateos, I, Velasco Roces, L, Fernández Laguna, CL, Lozano Blazquez, A

“…Background and importanceAntifibrotics are an important alternative for the treatment of idiopathic pulmonary fibrosis (IPF) but long term follow-up studies of…”
Get full text

4CPS-166 Switching to alemtuzumab in patients with relapsing remitting multiple sclerosis by Arias, A, Blanc, R Menárguez, Torrón, A Martínez, Fernández, C Carriles, María, MC Rosado, Roces, L Velasco, García, I Zapico, Lozano-Blázquez, A

“…BackgroundAlemtuzumab is a monoclonal antibody directed against the CD52 antigen on T- and B-lymphocytes indicated in adult patients with relapsing remitting…”
Get full text

4CPS-184 Comparison of safety and adherence of new oral therapies for the treatment of relapsing-remitting multiple sclerosis by Torròn, A Martinez, María, MC Rosado, Martínez, A Arias, Fernandez, C Carriles, Romeo, A Llorente, Blanc, R Menarguez, López, E Lázaro, Ferreras, A Rodriguez, López, A Pieras, Tamames, B Zárate, Lozano-Blazquez, A

“…BackgroundTeriflunomide and dimethylfumarate are two new oral therapies for relapsing-remitting multiple sclerosis (RRMS). Due to the increase in patients with…”
Get full text